| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10135-737-60 | 10135-737 | HUMAN PRESCRIPTION DRUG | Selegiline Hydrochloride | Selegiline Hydrochloride | CAPSULE | ORAL | 20210501 | N/A | ANDA | ANDA075352 | Marlex Pharmaceuticals, Inc. | SELEGILINE HYDROCHLORIDE | 5 mg/1 | 60 CAPSULE in 1 BOTTLE (10135-737-60) |
| 70954-504-10 | 70954-504 | HUMAN PRESCRIPTION DRUG | Selegiline Hydrochloride | Selegiline Hydrochloride | CAPSULE | ORAL | 20210401 | N/A | ANDA | ANDA075352 | Novitium Pharma LLC | SELEGILINE HYDROCHLORIDE | 5 mg/1 | 60 CAPSULE in 1 BOTTLE (70954-504-10) |
| 70954-504-20 | 70954-504 | HUMAN PRESCRIPTION DRUG | Selegiline Hydrochloride | Selegiline Hydrochloride | CAPSULE | ORAL | 20210401 | N/A | ANDA | ANDA075352 | Novitium Pharma LLC | SELEGILINE HYDROCHLORIDE | 5 mg/1 | 1000 CAPSULE in 1 BOTTLE (70954-504-20) |